Ads
-
Related paper
- USING OF LONG ACTION ERYTHROPOES STIMULATED AGENTS FOR TREATMENT OF ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASES V D ST
- CLINICAL AND ECONOMIC ANALYSIS OF USING OF LONG ACTION ERYTHROPOES STIMULATED AGENTS FOR THE TREATMENT OF ANEMIA CKD V HD PATIENTS
- Anemia in Patients with Chronic Kidney Disease
- Non-Heme Iron Panel in Patients with Anemia and Chronic Kidney Disease
- Halitosis in Patients with End-Stage Chronic Kidney Disease Undergoing Chronic Dialysis Treatment
- Clinical Study of Tongue Coating in Patients with Chronic Kidney Disease Undergoing Chronic Dialysis Treatment
- The problem of anemia treatment in patients with chronic heart failure
- EFFICACY AND SAFETY OF IRON (III)–HYDROXIDE SUCROSE COMPLEX IN CORRECTION OF ANEMIA STAGE 5D CHRONIC KIDNEYDISEASE HEMODIALYSIS PATIENTS NOT TREATED BY ERYTHROPOIESIS–STIMULATING AGENTS (PROSPECTIVEANALYSIS)
- Significance of Von Willebrand Factor-Cleaving Protease Activity in Patients with Chronic Kidney Diseases
- Can body shape index indicate obesity-associated inflammation and cardiovascular diseases in stage 3-4 chronic kidney disease patients?